These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 237080)

  • 21. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
    Lawrence RA; Jones RL; Wilson NH
    Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro models in the study of structure-activity relationships of narcotic analgesics.
    Kosterlitz HW; Waterfield AA
    Annu Rev Pharmacol; 1975; 15():29-47. PubMed ID: 238462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis.
    Dehpour AR; Rastegar H; Jorjani M; Roushanzamir F; Joharchi K; Ahmadiani A
    J Pharmacol Exp Ther; 2000 Jun; 293(3):946-51. PubMed ID: 10869396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of morphine on the neuro-effector transmission in the guinea-pig ileum and in the mouse vas deferens.
    Ito Y; Tajima K
    J Physiol; 1980 Oct; 307():367-83. PubMed ID: 6259338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous opioid peptides: multiple agonists and receptors.
    Lord JA; Waterfield AA; Hughes J; Kosterlitz HW
    Nature; 1977 Jun; 267(5611):495-9. PubMed ID: 195217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of intrinsic activity to the action of opioids in vitro.
    Miller L; Shaw JS; Whiting EM
    Br J Pharmacol; 1986 Mar; 87(3):595-601. PubMed ID: 3801765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-N,N'-but-2-ene-1,4-diylbimorphinans.
    Schmidhammer H; Smith CF; Dalkner E; Erlach D; Heuberger M; Rollinger JM
    Pharmazie; 1991 Feb; 46(2):101-2. PubMed ID: 1649476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evidence from functional studies for somatostatin receptor heterogeneity in guinea-pig isolated ileum, vas deferens and right atrium.
    Feniuk W; Dimech J; Jarvie EM; Humphrey PP
    Br J Pharmacol; 1995 Jul; 115(6):975-80. PubMed ID: 7582529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of mu opioid receptors in the mouse vas deferens for the study of opiate tolerance.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1989 Dec; 174(2-3):267-71. PubMed ID: 2560981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 14-alkoxymorphinans, V: 6-Deoxyocyprodime, an opioid antagonist with decreased mu receptor selectivity in comparison to cyprodime.
    Schmidhammer H; Jennewein HK; Smith CF
    Arch Pharm (Weinheim); 1991 Apr; 324(4):209-11. PubMed ID: 1650547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and opioid activity of new fentanyl analogs.
    Girón R; Abalo R; Goicoechea C; Martín MI; Callado LF; Cano C; Goya P; Jagerovic N
    Life Sci; 2002 Jul; 71(9):1023-34. PubMed ID: 12088762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of opiate tolerance may dissociate from dependence.
    Wüster M; Schulz R; Herz A
    Life Sci; 1982 Oct 18-25; 31(16-17):1695-8. PubMed ID: 6891426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
    Gao P; Larson DL; Portoghese PS
    J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3.
    Ward SJ; Pierson AK; Michne WF
    Life Sci; 1983; 33 Suppl 1():303-6. PubMed ID: 6319882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships for dermorphin-related tetrapeptides.
    Sarto G; Borea PA; Salvadori S; Tomatis R
    Pharmacology; 1984; 29(1):56-60. PubMed ID: 6540456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
    Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.